Sirolimus-eluting stents or vascular brachytherapy for in-stent restenosis after 3-year follow-up of the SISR (Sirolimus-Eluting Stent Versus Vascular Brachytherapy for In-Stent Restenosis) trial: a call for caution?

Rodriguez, Alfredo E

Sirolimus-eluting stents or vascular brachytherapy for in-stent restenosis after 3-year follow-up of the SISR (Sirolimus-Eluting Stent Versus Vascular Brachytherapy for In-Stent Restenosis) trial: a call for caution? [electronic resource] - JACC. Cardiovascular interventions Jan 2009 - 75-6; author reply 76-7 p. digital

Publication Type: Comment; Letter

1876-7605

10.1016/j.jcin.2008.11.001 doi


Brachytherapy
Coronary Restenosis--drug therapy
Drug-Eluting Stents
Humans
Immunosuppressive Agents--therapeutic use
Sirolimus--therapeutic use